Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe
  • Home
  • mortality prediction
Early Portopulmonary Hypertension in Cirrhosis: A Prognostic Marker of Increased Mortality
Posted inCardiology Gastroenterology news

Early Portopulmonary Hypertension in Cirrhosis: A Prognostic Marker of Increased Mortality

Posted by MedXY By MedXY 10/27/2025
Early-stage portopulmonary hypertension, defined by revised 2022 ESC/ERS criteria, independently predicts mortality in patients with cirrhosis, underscoring the importance of systematic screening and early intervention.
Read More
Integrating Triglyceride-Glucose Indices with Obesity Measures Enhances Cardiovascular and Mortality Risk Prediction in CKM Syndrome
Posted inCardiology Nephrology news

Integrating Triglyceride-Glucose Indices with Obesity Measures Enhances Cardiovascular and Mortality Risk Prediction in CKM Syndrome

Posted by MedXY By MedXY 10/19/2025
This study demonstrates that triglyceride-glucose-related indices combined with obesity measures significantly predict cardiovascular outcomes and mortality in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3, offering improved prognostic utility.
Read More
Enhanced GRACE 3.0 Score for Personalized Management of Non-ST-Elevation Acute Coronary Syndrome: Insights from a Multinational Validation Study
Posted inCardiology Specialties

Enhanced GRACE 3.0 Score for Personalized Management of Non-ST-Elevation Acute Coronary Syndrome: Insights from a Multinational Validation Study

Posted by MedXY By MedXY 10/19/2025
The updated GRACE 3.0 scoring system improves mortality prediction and personalizes early invasive treatment decisions in non-ST-elevation acute coronary syndrome across ten countries, demonstrating excellent validation and clinical utility.
Read More
NT-proBNP as a Prognostic Biomarker for Mortality in Ischemic Stroke: Insights from a Comprehensive Meta-Analysis
Posted inCardiology news Pathology & Lab Medicine Specialties

NT-proBNP as a Prognostic Biomarker for Mortality in Ischemic Stroke: Insights from a Comprehensive Meta-Analysis

Posted by MedXY By MedXY 08/21/2025
This systematic review and meta-analysis evaluates NT-proBNP's accuracy in predicting mortality among ischemic stroke patients, revealing moderate to high prognostic performance with potential clinical utility in risk stratification.
Read More
Decoding the Link Between Pulmonary Artery Pressures and Mortality in Chronic Heart Failure Patients
Posted inCardiology Clinical Updates news Respiratory Specialties

Decoding the Link Between Pulmonary Artery Pressures and Mortality in Chronic Heart Failure Patients

Posted by MedXY By MedXY 08/17/2025
Remote monitoring of systolic, diastolic, and mean pulmonary artery pressures predicts 2-year all-cause mortality in chronic heart failure across ejection fraction categories, informing personalized management strategies.
Read More
Predicting Long-Term Mortality: Insights from a Multi-Metabolite Signature in the PREDIMED Trial
Posted inDiabetes & Endocrinology news Specialties

Predicting Long-Term Mortality: Insights from a Multi-Metabolite Signature in the PREDIMED Trial

Posted by MedXY By MedXY 08/11/2025
A study identified a robust plasma multi-metabolite signature that predicts long-term all-cause mortality in participants from the PREDIMED trial and several US cohorts, providing new insights into metabolic biomarkers.
Read More
  • Inhaled Insulin for Pediatric Type 1 Diabetes: Analyzing the INHALE-1 Trial Results and Clinical Implications
  • Use of Teplizumab to Modulate Stage 2 Type 1 Diabetes in Two Individuals With Autoimmune Polyendocrine Syndrome 1
  • Beyond Glucose: SGLT-2 Inhibitors and GLP-1 Receptor Agonists Slow Frailty Progression in Older Adults
  • Beyond the Heart: Why Metabolic Gains Are the True Drivers of GLP-1RA Cardioprotection
  • Tirzepatide Shows Unprecedented Weight Loss and Reduced Insulin Demand in Adults with Type 1 Diabetes and Obesity
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号

  • English
  • 日本語
  • Tiếng Việt
  • 中文

aging Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer cardiovascular disease cardiovascular health cardiovascular risk chronic kidney disease clinical trial clinical trials critical care depression diabetes epidemiology exercise health heart failure Hypertension immunotherapy inflammation MASLD mental health metformin Mortality multiple myeloma nutrition obesity older adults Pediatrics Physical Activity Pregnancy prevention prostate cancer public health randomized clinical trial randomized controlled trial randomized trial SGLT2 inhibitors targeted therapy treatment type 2 diabetes weight loss women's health

Your health, we care

Copyright 2025 — Medxy AI. All rights reserved.
Scroll to Top
Sign in